Imagene

ImageneImagene
Imagene

Imagene

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

2020Active38
Rate

About

Imagene provides a SaaS platform powered by its Cross-Modality Intelligence Engine, which analyzes imaging, molecular, and clinical data to discover biomarkers, expand indications, and identify patients. This engine enables biopharma and clinical teams to derive actionable insights for optimizing trial design and improving therapeutic success.

Technology stack

detected 2026-06-27
CDN
AWS CloudFront
EmailGoogle Workspace
Hosting
AWS
Stack
jQueryWordPress
Analytics
Google Analytics 4Google Tag Manager
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Imagene do?

Imagene provides a SaaS platform powered by its Cross-Modality Intelligence Engine, which analyzes imaging, molecular, and clinical data to discover biomarkers, expand indications, and identify patients. This engine enables biopharma and clinical teams to derive actionable insights for optimizing trial design and improving therapeutic success.

How much funding has Imagene raised?

Imagene has raised a total of $45M in funding. The most recent round on record is Series B.

Where is Imagene headquartered?

Imagene is headquartered in Tel Aviv, Israel.

When was Imagene founded?

Imagene was founded in 2020.

What industry does Imagene operate in?

Imagene operates in Healthcare, Genomics, Cancer, Personalized, Therapy, HealthTech.

How many employees does Imagene have?

Imagene has approximately 38 people on record.

What is Imagene's revenue?

StartupHub estimates Imagene's annual revenue at $12.5M (range $6.6M to $19.9M, 63% confidence), based on comparable companies in the sector.

What is Imagene's valuation?

StartupHub estimates Imagene's effective valuation at $184.9M (range $111.3M to $267.0M, 19% confidence), based on comparable companies in the sector.